Results for tag: "Palivizumab"

Palivizumab is a monoclonal antibody used to prevent serious lower respiratory tract infections caused by respiratory syncytial virus (RSV) in certain high-risk infants and children. It is used to reduce the risk of hospitalization due to RSV in infants and children at risk of severe RSV disease. Palivizumab is administered as a monthly intramuscular injection during the RSV season, which typically runs from November to March in the Northern Hemisphere. Palivizumab is a key drug in the infectious diseases drugs market, as it is the only approved therapy for the prevention of RSV infection in high-risk infants and children. It is used in combination with other preventive measures, such as handwashing and avoiding contact with people who have RSV. Palivizumab is marketed by several companies, including AstraZeneca, GlaxoSmithKline, Merck, and Pfizer. It is also available as a generic drug in some countries. Show Less Read more